Dr. Titus J Rund, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 36000 Darnall Loop, Credentials Office, Fort Hood, TX 76544 Phone: 254-288-8568 |
Dr. Eric Heppner, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8090 |
Grace Baik, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Carl R. Darnall Army Medical Center, 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8000 |
Dr. Kevin Michael Cron, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 36000 Darnall Loop, Fort Hood, TX 76544 Phone: 254-288-8680 |
Luke Robert Murphy, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 36065 Santa Fe Ave, Attn: Department Of Emergency Medicine, Fort Hood, TX 76544 Phone: 254-553-1364 |
Alec Pawlukiewicz, MD General Practice Medicare: Medicare Enrolled Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8000 |
Dr. Theresa Marie Bureau-long, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 36000 Darnall Loop, Carl R. Darnall Army Medical Center, Fort Hood, TX 76544 Phone: 254-288-8234 |
Peter E Carr, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-553-9089 |
Connor Francis Ford, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8000 |
Dr. Dean Miller, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Thomas Moore Clinic, 2245 761st Tank Battalion Avenue, Fort Hood, TX 76544 Phone: 254-285-6230 |
Dr. David L Waite, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 36000 Darnall Loop, Carl R. Darnall Army Medical Center, Fort Hood, TX 76544 Phone: 254-288-8025 Fax: 254-286-7326 |
Carol Kay Yee, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: Carl R. Darnall Army Medical Center, 36000 Darnall Loop, Fort Hood, TX 76544 Phone: 254-288-8025 |
Dr. Kyle Krisitian Sokol, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 253-225-6622 |
Andrew Mark Glenn, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8000 |
Dr. Jennifer M Hein, MD General Practice Medicare: Medicare Enrolled Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8000 |
Connor Thrun, DO General Practice Medicare: Medicare Enrolled Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8000 |
Dr. Joy Alvarado, MD, MHS General Practice Medicare: Not Enrolled in Medicare Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8280 |
Dr. Robert D Hales, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 36000 Darnall Loop, Fort Hood, TX 76544 Phone: 706-787-1648 |
Thomas Gilder, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-553-4614 |
Corey Herman, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 36065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8280 |
News Archive
Idera Pharmaceuticals, Inc. today presented data showing that IMO-4200, a dual agonist of Toll-like receptor (TLR) 7 and TLR8, in combination with approved cancer treatments, rituximab or bortezomib, significantly increased antitumor activity in several preclinical lymphoma models. The presentation, entitled "Antitumor Activity of an RNA-Based Agonist of TLR7 and 8 in Preclinical Models of Hematological Malignancies," was made at the 52nd Annual Meeting of the American Society for Hematology in Orlando, Florida by Idera scientists.
The American Association for Cancer Research will host its first Frontiers in Basic Cancer Research Meeting in Boston from Oct. 8-11, 2009. The meeting is expected to draw nearly 500 leading scientists to present on high-profile topics like epigenetics, metastasis and systems biology, and create synergies among the many subfields of basic science.
The U.S. Food and Drug Administration today is announcing the approval of Merck's redesigned drug container labels that include a new standardized format to improve readability and provide better information on product and strength differentiation.
Intarcia Therapeutics, Inc. today announced the start of enrollment for a phase 2 study comparing its proprietary drug candidate ITCA 650 (DUROS continuous delivery of exenatide) with Byetta, an FDA-approved twice-daily injection form of exenatide.
The discoveries in the cellular and molecular biology of cancer, the development of drugs against specific genetic mutations, and the emergence of immunotherapy are allowing the cure or improvement of the quality of life and life expectancy of patients with tumors.
› Verified 3 days ago